Oxygen saturation >= 92% on room air

No evidence of dyspnea at rest, no exercise intolerance due to pulmonary insufficiency, and a pulse oximetry > 92% while breathing room air

Pulse oximetry > 94% on room air if there is clinical indication for determination (e.g. dyspnea at rest)

Pulse oximetry > 94% on room air if there is clinical indication for determination (e.g. dyspnea at rest)

Subjects who need daily oxygen therapy

Excluded if known active pulmonary disease with hypoxia defined as: \r\n* Oxygen saturation < 85% on room air, or\r\n* Oxygen saturation < 88% despite supplemental oxygen

No evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry > 94% if there is clinical indication or determination; pulmonary function tests (PFTs) are not required

No evidence of dyspnea at rest, no exercise intolerance, and a resting pulse oximetry reading > 94% on room air if there is clinical indication for determination

No evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry > 94% at sea level if there is clinical indication for determination

For children who are unable to cooperate for PFTs, the criteria are: no evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry reading of > 92% on room air

Patients with a history of pulmonary dysfunction must have no evidence of dyspnea at rest, no exercise intolerance due to pulmonary insufficiency, and a pulse oximetry > 92% while breathing room air unless current dysfunction is due to the lymphoma in which case the patient is eligible

Pulse oximetry > 94% on room air if there is clinical indication for determination (e.g. dyspnea at rest)

Normal pulmonary function tests (including diffusion capacity of the lung for carbon monoxide [DLCO]) if there is clinical indication for determination (e.g. dyspnea at rest, known requirement for supplemental oxygen); for patients who do not have respiratory symptoms or requirement for supplemental oxygen, pulmonary function tests (PFTs) are NOT required

Patients requiring any daily supplemental oxygen

Requirement for daily supplemental oxygen

Pulse oximetry of > 95% on room air in patients who previously received radiation therapy

Resting baseline oxygen saturation >= 92% at rest - by pulse oximetry, performed within 14 days of treatment initiation

Dependence on continuous supplemental oxygen use

Normal pulmonary functions tests (including carbon monoxide diffusing capability test [DLCO]) if there is a clinical indication for determination (dyspnea at rest, known requirement for supplemental oxygen); for subjects who do not have respiratory symptoms (no dyspnea at rest, oxygen [O2] saturation [sat] >= 93% on room air), full pulmonary function tests (PFTs) are NOT required

TREATMENT: Pulse oximetry of > 95% on room air in patients who previously received radiation therapy

Pulse oximetry of > 90% on room air

Patients with oxygen (O^2) saturations > 93% on room air (measured by pulse oximetry)

Baseline pulse oximetry < 94% or requires oxygen supplementation of any kind

Obtained within 14 days prior to C1D1: Oxygen saturation (O2 Sat.) >= 92% on ambient air

Baseline oxygen saturation > 92% on room air

Carbon monoxide diffusing capability (DLCO) > 60% predicted (in children, oxygen [O2] saturation > 92% on room air)

Pulse oximetry of > 95% on room air

INCLUSION - TREATMENT: Pulse oximetry of > 90% on room air

Subjects must have adequate lung function to permit surgical resection determined by pre-enrollment pulmonary function tests to include diffusion capacity of the lung for carbon monoxide (DLCO) as follows:\r\n* DLCO >= 70% predicted OR DLCO < 70% but >= 55% with an oxygen consumption (VO2) max >= 10 L/min/kg (assessed by cardiopulmonary exercise testing) or 6 minute walk test >= 500 meters\r\n* Subjects with a DLCO < 55% are excluded from this study\r\n* Subjects must have a baseline oxygen (O2) saturation by pulse oximetry that is >= 92% both at rest and while walking, off supplemental oxygen

If clinical indications, pulse oximetry > 94% on room air

Patients must have normal pulmonary function testing for age based on pulse oximetry

Uncontrolled asthma or O2 saturation < 90% by arterial blood gas analysis or pulse oximetry on room air

INCLUSION - INFUSION: Pulse oximetry of > 90% on room air

TREATMENT INCLUSION: Pulse oximetry of > 90% on room air

Pulse oximetry < 92% on room air

Oxygen saturation < 90% measured by pulse oximetry at rest

The patient is oxygen-dependent.

Pulse oximetry of > 90% on room air

Pulse oximetry of > 90% on room air

Pulse oximetry > 93% on room air and no evidence of dyspnea at rest

INCLUSION CRITERIA FOR STRATUM C: Pulse oximetry > 93% on room air and no evidence of dyspnea at rest

Patients without respiratory symptoms (e.g. dyspnea at rest, known requirement for supplemental oxygen therapy) and who have an oxygen saturation > 92% on room air, will be eligible; for patients not meeting this criteria, pulmonary function tests will be performed to confirm that the diffusion capacity of the lung for carbon monoxide (DLCO)/alveolar volume (VA)/Adj is 50% of the normal predicted value corrected for hemoglobin and alveolar volume in order to meet eligibility\r\n* (For children who are unable to cooperate for pulmonary function test [PFT]s, the criterion is: No evidence of dyspnea at rest, no exercise intolerance and no requirement for supplemental oxygen therapy)

ELIGIBILITY CRITERIA AT TIME OF TREATMENT: Pulse oximetry of > 90% on room air

Pulse oximetry of > 95% on room air in patients who previously received radiation therapy

DLCO corrected < 50%; patients who are unable to perform pulmonary function tests (for example, due to young age and/or developmental status) will be excluded if the O2 saturation is < 92% on room air; patients with a DLCO 50-60% must also have a partial pressure of oxygen (pO2) of > 80 mmHg

Oxygen saturation >= 90%, no more than 2 liters per minute (LPM) oxygen

Pulse oximetry of > 90% on room air

Adequate respiratory function defined as not requiring supplemental oxygen or mechanical ventilation; oxygen saturation 90% or higher on room air

RETREATMENT WITH MODIFIED T-CELLS INCLUSION CRITERIA: Oxygen saturation 90% or higher on room air

INCLUSION - TREATMENT: Pulse oximetry of ? 90% on room air

Within 4 weeks prior to study enrollment: Pulse oximetry > 94% on room air or oxygen (O2) by nasal cannula

Oxygen saturation >= 90% by pulse oximetry

Patients with baseline respiratory insufficiency severe enough to require supplemental oxygen.

Pulse oximetry >= 94% if there is clinical indication for determination

TREATMENT WITH SJCAR19: Forced vital capacity (FVC) >= 50% of predicted value; or pulse oximetry >= 92% on room air if patient is unable to perform pulmonary function testing

No evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry > 94%

Pulmonary function\r\n* Baseline oxygen saturation > 92% on room air at rest \r\n* Patients with respiratory symptoms must have a diffusing capacity of the lungs for carbon monoxide (DLCO)/adjusted > 45%; for children who are unable to cooperate for pulmonary function tests (PFTs) they must not have dyspnea at rest or known requirement for supplemental oxygen

Must have an ambulatory oxygen saturation of > 90% on room air

Resting baseline oxygen (O2) saturation by pulse oximetry of ? 92% at rest

Baseline oxygen saturation > 92% on room air

Patients/subjects who need daily oxygen therapy

Must have a minimum level of pulmonary reserve defined as ? grade 1 dyspnea and pulse oximetry of ? 88% on room air

Adequate respiratory function defined as not requiring supplemental oxygen or mechanical ventilation; oxygen saturation 90% or higher on room air

Pulse oximetry > 94% on room air

Patients who have any clinical evidence of hypoxia with O2 saturation less than 92% on room air.

A pulse oximetry ? 93%

Adequate respiratory function defined as not requiring supplemental oxygen or mechanical ventilation; oxygen saturation 90% or higher on room air

Baseline oxygen saturation > 92% on room air

Patients who have a significant history of pulmonary disease that necessitates the use of supplemental oxygen, and patients with resting pulse oximetry < 92% on room air

Pulse oximetry > 94% on room air

Pulse oximetry oxygen (O2) saturation < 90% at rest on room air

Adequate respiratory function defined as not requiring supplemental oxygen or mechanical ventilation; oxygen saturation 90% or higher on room air

Subject does not require supplemental oxygen or mechanical ventilation, and oxygen saturation by pulse oximetry is 94% or higher on room air.

Common Terminology Criteria for Adverse Events (CTCAE) grade =< 1 dyspnea and oxygen saturation (SaO2) >= 92% on room air

Oxyhemoglobin saturation at rest >= 95% (off supplemental oxygen)

Use of continuous oxygen

Adequate pulmonary function as assessed by >= 92% oxygen saturation on room air by pulse oximetry

Adequate pulmonary function as assessed by >= 92% oxygen saturation on room air by pulse oximetry

Oxygen saturation >= 90% on room air

No clinically significant pleural effusion, baseline oxygen saturation > 92% on room air

Pulse oximetry >= 92% on room air at rest

Room air oxygen saturation of 92% or greater

Baseline oxygen saturation > 92% on room air

Pulmonary dysfunction defined as:\r\n* Severe pulmonary dysfunction with (1) a hemoglobin corrected DLCO < 40% of predicted at the Baseline Screening visit, or (3) FVC < 45% of predicted Baseline Screening visit, or\r\n* Partial pressure (pO2) < 70 mmHg or pCO2 >= 45 mmHg without supplemental oxygen, or \r\n* O2 saturation < 92% at rest without supplemental oxygen as measured by forehead pulse oximeter

Patients/subjects who need daily oxygen therapy

Uncontrolled asthma or oxygen saturation < 90% by arterial blood gas analysis or pulse oximetry on room air.

CELL PROCUREMENT: Subjects may not have an oxygen requirement as defined by pulse oximetry of < 90% on room air

LYMPHODEPLETION: Subjects may not have an oxygen requirement as defined by pulse oximetry of < 90% on room air

Must not require supplemental oxygen or have a pulse oximetry < 92% on room air

Patients requiring oxygen therapy

Patients requiring oxygen therapy

The patient has adequate pulmonary function per protocol and oxygen saturation >92% on room air.

Patients requiring continuous supplemental oxygen are excluded to avoid possible complications from pneumonitis

For patients < 8 years of age unable to perform pulmonary function tests (PFTs) due to age or developmental ability: (1) no evidence of dyspnea at rest and (2) no need for supplemental oxygen and (3) oxygen (O2) saturation > 92% on room air

Must have an ambulatory oxygen saturation of > 88% on room air

Must have an ambulatory oxygen saturation of > 90% on room air

Forced vital capacity (FVC) >= 40% of predicted value; or pulse oximetry >= 92% on room air if patient is unable to perform pulmonary function testing

Oxygen saturation >= 90% on room air and adjusted diffusing capacity of the lungs for carbon monoxide (DLCO) of at least 40%

Need for supplemental oxygen

No evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry > 94%

PRIOR TO INFUSION OF ATLCAR.CD30 CELLS: Pulse oximetry of > 90% on room air

Room air oxygen saturation of 92% or greater

Has a pulse oximetry < 92% on room air

Must have a minimum level of pulmonary reserve defined as =< grade 1 dyspnea, pulse oxygen > 92% on room air, and carbon monoxide diffusing capability test (DLCO) >= 40% (corrected for anemia)

Patient has a pulse oximetry of < 92% on room air

Subjects must have resting baseline oxygen (O2) saturation by pulse oximetry of >= 92% at rest

Pulse Oximetry measurement ? 95% saturation without supplemental oxygen

Oxygen saturation over 90% by pulse oximetry without administration of supplemental oxygen

Baseline oxygen saturation > 92% on room air and no clinically significant pleural effusion

No supplemental oxygen requirement

Pulse oximetry of > 95% on room air

ELIGIBILITY CRITERIA- LYMPHODEPLETION/INFUSION OF tvs-CTL: Pulse oximetry of > 95% on room air

Patient has a pulse oximetry of < 92% on room air

Patient is on supplemental home oxygen

ADDITIONAL CRITERIA FOR STUDY CONTINUATION: Patient has a pulse oximetry of < 92% on room air

ADDITIONAL CRITERIA FOR STUDY CONTINUATION: Patient is on supplemental home oxygen

AT THE TIME OF INFUSION: Pulse oximetry of ? 90% on room air

Adequate pulmonary function as defined as: no evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry > 94% if there is clinical indication for determination

TREATMENT: Pulse oximetry of > 90% on room air

Patients must have clinically normal lung function as manifested by no dyspnea at rest and no oxygen requirement

No evidence of dyspnea at rest and pulse oximetry > 94%

Not requiring supplemental oxygen or mechanical ventilation; oxygen saturation 90% or higher on room air; no dyspnea at rest

ELIGIBILITY CRITERIA FOR T-CELL PRODUCT INFUSION: Not requiring supplemental oxygen or mechanical ventilation, oxygen saturation 90% or higher on room air and no dyspnea at rest

RETREATMENT WITH MODIFIED T CELLS: Oxygen saturation 90% or higher on room air

RETREATMENT WITH MODIFIED T CELLS: Patient requiring supplemental oxygen or mechanical ventilation

TREATMENT: Pulse oximetry of > 93% on room air in patients who previously received radiation therapy

Requirement for FiO2 > 0.5 to maintain arterial oxygen saturation > 90%

Children unable to perform pulmonary function tests (e.g., less than 7 years old) pulse oximetry of >= 92% on room air

Normal lung function as manifested by no dyspnea at rest and no oxygen requirement

ELIGIBILITY CRITERIA TO UNDERGO OPTIONAL T CELL ABLATION\r\n* Research participant has >= 1% CAR T cells in the peripheral blood\r\n* Pulmonary: not requiring supplemental oxygen or mechanical ventilation, oxygen saturation 90% or higher on room air\r\n* Cardiovascular: not requiring pressor support, no symptomatic cardiac arrhythmias, no acute coronary syndrome, or uncontrolled hypertension\r\n* Renal Function: serum creatinine did NOT increase by more than 2.5 fold from baseline (at time of screening)\r\n* Liver Function: adequate liver function defined as total bilirubin =< 3.0 mg/dl \r\n* AST =< 5 x ULN, ALT =< 5 x ULN\r\n* Neurological: research participant without clinically significant encephalopathy/new focal deficits\r\n* Infectious diseases: no clinical evidence of uncontrolled active infectious process

Not requiring supplemental oxygen or mechanical ventilation, oxygen saturation 90% or higher on room air

(ELIGIBILITY CRITERIA AT TIME OF INFUSION OF GENETICALLY MODIFIED AUTOLOGOUS T CELLS): Not requiring supplemental oxygen or mechanical ventilation, oxygen saturation 90% or higher on room air

Not requiring supplemental oxygen or mechanical ventilation, oxygen saturation 90% or higher on room air

Pulmonary: not requiring supplemental oxygen or mechanical ventilation, oxygen saturation 90% or higher on room air

Pulmonary criteria: not requiring supplemental oxygen or mechanical ventilation, oxygen saturation 90% or higher on room air

Receiving supplementary continuous oxygen

Pulse oximetry of > 90% on room air

Normal oxygen saturation at baseline ABG (arterial blood gas) testing

For children who are unable to perform pulmonary function tests but have no evidence of dyspnea at rest nor exercise intolerance nor abnormal chest X-ray (CXR), a pulse oximetry > 94% on room air is acceptable

Baseline oxygen saturation of < 85% or partial pressure of oxygen in arterial blood (PaO2) < 70

Must have a minimum level of pulmonary reserve defined as =< grade 1 dyspnea and pulse oxygen > 92% on room air

Diffusing capacity of the lung for carbon monoxide (DLCO) equal or greater than 50% predicted corrected for hemoglobin; for children =< 7 years of age who are unable to perform pulmonary function tests (PFT), oxygen saturation >= 92% on room air by pulse oximetry

Oxygen saturation >= 90% on room air

Patients must have no evidence of dyspnea at rest and a pulse oximetry > 92% while breathing room air

RANDOMIZED PHASE II (ARMS K AND L): Patients must have no evidence of dyspnea at rest and a pulse oximetry > 92% while breathing room air

Pulse oximetry of > 90% on room air

Normal lung function as manifested by no dyspnea and/or oxygen saturation >= 94% on room air

Forced vital capacity (FVC) >= 50% of predicted value; or pulse oximetry >= 92% on room air if patient is unable to perform pulmonary function testing

Severe chronic obstructive or other pulmonary disease with hypoxemia (requires supplementary oxygen, symptoms due to hypoxemia or oxygen saturation <90% by pulse oximetry after a 2 minute walk) or in the opinion of the investigator any physiological state likely to cause systemic or regional hypoxemia

Pulse oximetry of > 90% on room air

Oxygen saturation >= 90% on room air, measured prior to treatment

Pulse oximetry > 94% if there is clinical indication for determination

Continuous oxygen use

Pulse oximetry of > 90% on room air

Pulse oximetry of >= 90% on room air

For children who are uncooperative for pulmonary function tests and have no evidence of dyspnea at rest or exercise intolerance, pulse oximetry > 94% on room air is considered acceptable, with a normal chest X-ray

Adequate pulmonary function as assessed by >= 92% oxygen saturation on room air by pulse oximetry

Oxygen saturation > 92%

Dyspnea at rest due to complications of advanced malignancy or other disease requiring continuous oxygen therapy.

Evidence of dyspnea at rest or oxygen saturation (<=) 94 percent (%).

Current dyspnea at rest of any origin, or other diseases requiring continuous oxygen therapy.

Normal lung oxygen saturation by pulse oximeter, as determined by the Principal Investigator based on patient history and status.

Respiratory failure (defined as oxygen saturation [SaO2] < 90% on room air; partial pressure of carbon dioxide [PCO2] > 45mmHg; or forced expiratory volume in one second [FEV1] <1.0 liter).

No clinically significant pleural effusion, baseline oxygen saturation > 92% on room air

No clinically significant pleural effusion, baseline oxygen saturation > 92% on room air.

Oxygen saturation (Sp02) of less than 95% on room air

ENROLLMENT: Pulmonary symptoms controlled by medication and pulse oximetry >= 92% on room air.

Within 14 days of study registration: No oxygen requirement on room air or requiring =< 2L supplemental oxygen (O2)

Within 14 days of study registration (30 days for pulmonary and cardiac): oxygen saturation >= 90% on room air with no symptomatic pulmonary disease. If symptomatic or prior known impairment single breath carbon monoxide diffusing capacity (DLCOc) or >= 40%.

Current use of supplemental oxygen

Oxygen saturation as measured by pulse oximetry is > 93% on room air and no evidence of dyspnea at rest

No evidence of dyspnea at rest, no history of exercise intolerance, and a pulse oximetry > 94%

Any patient requiring supplemental oxygen therapy

Resting baseline oxygen (O2) saturation by pulse oximetry of >= 92% at rest

Resting oxygen saturation (O2 sat) must be >= 92%

Within 30 days of registration: Oxygen saturation >= 90% on room air

Patients must not require daily supplemental oxygen

Pulse oximetry > 94% on room air

Oxygen saturation >= 92% on room air

Oxygen saturation on room air > 92 % by pulse oximetry; (patients on intermittent or continuous supplemental oxygen are not allowed)

Known severely impaired lung function (spirometry and diffusing capacity of the lung for carbon monoxide [DLCO] 50% or less of normal and oxygen [O2] saturation 88% or less at rest on room air)

Uncontrolled asthma or oxygen (O2) saturation < 90% by ABG (arterial blood gas) analysis or pulse oximetry on room air

No requirement for supplemental oxygen therapy

With impaired pulmonary function as evidenced by partial pressure of oxygen (pO2) < 70 mm Hg and carbon monoxide diffusing capability test (DLCO) < 70% of predicted or pO2 < 80 mm Hg and DLCO < 60% of predicted; (or, for pediatric patients unable to perform pulmonary function tests, then oxygen (O2) saturation < 92% on room air), or receiving supplementary continuous oxygen

Pulse oxygen (Ox) >= 90% on room air

Severely impaired lung function as defined as spirometry and DLCO (corrected for Hgb)\n             that is <50% of the normal predicted value and/or O2 saturation <88% at rest on room\n             air.

Severe hypoxemia with room air pulmonary arterial oxygen tension (PaO2) < 70, supplemental oxygen dependence, or DLCO < 50% predicted

Pulse oximetry of >= 90% on room air

Pulse oximetry of > 90% on room air

Patients requiring supplemental oxygen

Must have a minimum level of pulmonary reserve defined as ?Grade 1 dyspnea and pulse oxygenation > 91% on room air

Must have a minimum level of pulmonary reserve defined as ? Grade 1 dyspnea and pulse oxygenation > 91% on room air

Subject has resting baseline oxygen saturation by pulse oximetry of ? 92% at rest.

The patient is oxygen-dependent.

Participants requiring any daily supplemental oxygen

Must have a minimum level of pulmonary reserve as ? Grade 1 dyspnea and pulse oxygenation > 91% on room air.

O2 saturation < 92% (on room air).

Oxygen saturation on room air > 92 % by pulse oximetry; (subjects on intermittent or continuous supplemental oxygen are excluded)

> 90% oxygen saturation on room air by pulse oximetry

Uncontrolled asthma or oxygen saturation <90% by arterial blood gas analysis or pulse oximetry on room air;

Adequate oxygen saturation via pulse oximeter within 28 days prior to registration (i.e., patient can NOT have CTCAE hypoxia grade 2 or greater)

Resting baseline oxygen (O2) saturation by pulse oximetry of >= 92% at rest

Must have a minimum level of pulmonary reserve defined as =< grade 1 dyspnea and pulse oxygen > 92% on room air

Known severely impaired lung function, including: • CTCAE grade 2 (or greater) hypoxia (decreased oxygen saturation with exercise [e.g., pulse oximeter <88%]; intermittent supplemental oxygen)

Patients requiring supplemental oxygen therapy

Severe chronic obstructive or other pulmonary disease with hypoxemia (requires supplementary oxygen, symptoms due to hypoxemia or oxygen [O2] saturation < 90% by pulse oximetry after a 2 minute walk or in the opinion of the investigator any physiological state likely to cause systemic or regional hypoxemia)

Oxygen saturation >= 90% on room air

Adequate pulmonary function defined as:\r\n* No evidence of dyspnea at rest, no exercise intolerance, no chronic oxygen requirement, and room air pulse oximetry > 94% if there is a clinical indication for pulse oximetry; normal pulmonary function tests in patients who are capable of cooperating with testing (including diffusion capacity of the lung of carbon monoxide [DLCO]) are required if there is a clinical indication for determination; for patients who do not have respiratory symptoms, full pulmonary function tests (PFTs) are NOT required

Pulse oximetry of > 90% on room air

Pulse oximetry of > 90% on room air

Normal pulmonary function tests (including diffusing capacity of the lungs for carbon monoxide [DLCO]) if there is clinical indication for determination (e.g. dyspnea at rest, known requirement for supplemental oxygen); Note: for patients who do not have respiratory symptoms or requirement for supplemental oxygen, pulmonary function tests (PFTs) are NOT required

The patient is oxygen-dependent.

Baseline oxygen saturation > 92% on room air

Resting and ambulatory oxygen saturation >= 94% on room air

Oxygen saturation as measured by pulse oximetry must be >= 93% on room air

Severe chronic obstructive or other pulmonary disease with hypoxemia (requires supplementary oxygen, symptoms due to hypoxemia or oxygen saturation < 90% by pulse oximetry after a 2 minute walk) or in the opinion of the investigator any physiological state likely to cause normal tissue hypoxia

Patient has a pulse oximetry of < 92% on room air

Patient is on supplemental home oxygen

Patients must not have any known uncontrolled underlying pulmonary disease or severely impaired lung function (spirometry and diffusing capacity of the lung for carbon monoxide [DLCO] 50% or less of normal and oxygen [O2] saturation 88% or less at rest on room air)

Dyspnea at rest or other diseases that require continuous oxygen therapy

AT THE TIME OF INFUSION: Pulse oximetry of > 90% on room air

Patients must have adequate lung function, as defined by oxygen saturation greater than or equal to 90% by pulse oximetry

Not requiring supplemental oxygen or mechanical ventilation, oxygen saturation 90% or higher on room air

Resting and walking oxygen (O2) saturation must remain above 90% at the time of screening

Patients with a pulse oximetry of < 92% on room air

Patients on supplemental home oxygen

Continuous oxygen use

Patients on oxygen

No evidence of dyspnea at rest, no exercise intolerance due to pulmonary insufficiency, and a pulse oximetry > 92% while breathing room air

Patients must demonstrate a respiratory rate that is within normal limits for age, measured when afebrile and at rest (measured for a full minute) and pulse oximetry >= 93% on room air

For pediatric patients unable to perform pulmonary function tests, oxygen (O2) saturation > 92% on room air

May not be on supplemental oxygen

Patient must not have a requirement for supplemental oxygen

Pulse oximetry greater than or equal to 92% on room air

Oxygen (O2) saturation at rest >= 90% (off supplementary oxygen)

No evidence of dyspnea at rest and a pulse oximetry > 94% if there is clinical indication for determination

Individuals with active lung disease as defined by presence of pulmonary infiltrates on screening chest x-ray or baseline room air oxygen saturation of < 92%

The patient must not be dependent on supplemental oxygen

Pulmonary function test (PFT) demonstrating a diffusion capacity of least 50% predicted; for children =< 7 years of age who are unable to perform PFT, oxygen saturation >= 92% on room air by pulse oximetry

Pulse oximetry of > 88%

Adequate pulmonary function as assessed by >= 92% oxygen saturation on room air by pulse oximetry

Oxygen saturation >= 95% on room air

Oxygen saturation >= 90% on room air

Oxygen saturation >= 90% on room air and diffusing capacity of the lung for carbon monoxide corrected (DLCOcor) >= 40%

Use of formalin or hyperbaric oxygen treatment

Significant lung disease (oxygen [O2] saturation less than 88% in room air)

Adequate pulmonary function as assessed by >= 92% oxygen saturation on room air by pulse oximetry

Pulmonary function - diffusion capacity of at least 50% predicted; children unable to perform pulmonary function tests (e.g. less than 7 years old) pulse oximetry of >= 92% on room air

Pulse oximetry of > 90% on room air

Pulmonary function test demonstrating a diffusion capacity of least 50% predicted (myeloablative regimen 4, reduced intensity regimen 3) or at least 40% predicted (nonmyeloablative regimen 2); for children < 7 years of age who are unable to perform pulmonary function test (PFT), oxygen saturation > 92% on room air by pulse oximetry

Patients must not have any evidence of dyspnea at rest, exercise intolerance, and must have a pulse oximetry > 94% at sea level

Hypoxia (oxygen saturation < 90% on room air) or in the opinion of the investigator any pulmonary compromise leading to hypoxia, at the time of study entry

Severe pulmonary dysfunction with a hemoglobin corrected DLCO < 30% or FVC < 40% of predicted or O2 saturation < 92% at rest without supplemental oxygen

A pulse oximetry ? 94% at sea level (? 90% at altitude ? 5000 feet) if there is clinical indication for determination.

FEV1, FVC > 50% of predicted; Note: If unable to perform pulmonary tests, then O2 saturation > 92% on room air.

Requirement of supplemental oxygen.

Oxygen saturation at rest or with exercise > 88% as measured by pulse oximeter or PaO2 > 55 mm Hg without need for supplemental oxygen at rest or with activity

Oxygen saturation of greater than or equal to 90% on room air

Oxygen saturation at rest by pulse oximetry less than 88% or partial pressure of oxygen (PaO2) less than or equal to 55 mm Hg

Severe chronic obstructive or other pulmonary disease with hypoxemia (requires supplementary oxygen, symptoms due to hypoxemia or oxygen saturation less than 90% by pulse oximetry after a 2 minute walk) or in the opinion of the investigator any physiological state likely to cause hypoxia of normal tissue.

Oxygen partial pressure (pO2) < 60% or carbon dioxide partial pressure (pCO2) >= 50 on room air arterial blood gas

Subjects must have a resting baseline oxygen (O2) saturation by pulse oximetry of >= 92% at rest

Baseline oxygen saturation >92% on room air

Requiring supplemental oxygen at more than 2 L/min

Oxygen saturation (Sp02) of less than 95% on room air.

Pulse oximetry of > 90% on room air

Dyspnea of any cause requiring supplemental oxygen therapy;

Participants requiring any daily supplemental oxygen

Pulse oximetry greater than or equal to 92% on room air

Patients with history of lung disease currently requiring any pharmacologic or supplemental oxygen treatment

Adequate pulmonary function defined as:\r\n* No dyspnea at rest\r\n* No known requirement for supplemental oxygen\r\n* No known active pneumonitis

Pulmonary function test (PFT) demonstrating a diffusion capacity of least 50% predicted; for children =< 7 years of age who are unable to perform PFT, oxygen saturation >= 92% on room air by pulse oximetry

Patients must have baseline pulse oximetry > 90% on room air

Pulse > 45 or < 120

Forced vital capacity (FVC) >= 40% of predicted value; or pulse oximetry >= 92% on room air if patient is unable to perform pulmonary function testing

Forced vital capacity (FVC) >= 50% of predicted value or pulse oximetry (Pox) >= 92% on room air

Patients must have baseline pulse oximetry > 90% on room air

O2 saturation < 92% (on room air), evidence of TLS > grade 2 (according to the Cairo-Bishop criteria (3)) or leukostasis (2).

The patient is oxygen-dependent.

Cohort A: Continuous oxygen use

Forced vital capacity (FVC) >= 40% of predicted value; or pulse oximetry >= 92% on room air if patient is unable to perform pulmonary function testing

Patient currently requiring supplemental oxygen for his/her daily life

Requirement for supplemental oxygen to carry out activities of daily living

If unable to perform pulmonary function tests due to young age, oxygen saturation > 92% on room air

Oxygen saturation <95% on room air by trans-cutaneous method or need for any supplemental oxygenation or ventilatory support, or increase in oxygen supplementation requirement of ?2 litres for subjects with chronic oxygen dependency. For those subjects with a history of chronic hypoxia (without supplemental oxygen), an oxygen saturation of at least 3% below the patient's historical baseline oxygen saturation will satisfy this criterion.

persistent arterial oxygen desaturation, arterial partial pressure of oxygen (PaO2) < 50 or oxygen saturation (SaO2) saturation < 80%,

Pulse oximetry >= 93% at room air

Impaired lung function: O2 saturation 88% or less at rest on room air by pulse oximetry; if O2 saturation is =< 88% at rest, further pulmonary function tests (PFTs) should be ordered to confirm normal pulmonary function and eligibility

No evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry > 94% in room air, if there is clinical indication for determination

Oxygen saturation >= 90% on room air

Room air oxygen saturation of > 94%

Pulse > 45 and < 120

Current dyspnea at rest, owing to complications of advanced malignancy or any requirement for supplemental oxygen to perform activities of daily living

Oxygen saturation < 90% despite supplemental oxygen > 6 L/minute.

Are receiving chronic oxygen therapy

Daily supplemental oxygen

Subjects currently on supplemental oxygen support

Patients with history of lung disease currently requiring any pharmacologic or supplemental oxygen treatment

Chronic supplemental oxygen requirement or hypoxemia < 92% blood oxygen saturation (SpO2)

Any patients requiring oxygen at baseline

Non-hypoxemic (i.e. oxygen saturation > 90% on ambient air)

Able to tolerate high-flow oxygen/air

Supplemental oxygen dependency

Tracheotomy or oxygen dependence at time of MBS

Partial pressure of arterial oxygen (PaO2):fraction of inspired oxygen (FiO2) ratio =< 300 mmHg OR a peripheral capillary oxygen saturation (SaO2):FiO2 =< 357

Oxygen saturation > 90% on ambient air at time of assessment

Patients who are oxygen dependent

Room air desaturation at rest =< 85%

Room air desaturation at rest =< 85%

Supplemental oxygen requirement > 6 L per minute

Patients requiring oxygen more than 2 liters

Adequate pulmonary function defined as:\r\n* Room air oxygen saturation of > 90% at altitude > 5000 feet, or > 93% < 5000 feet

No requirement for supplemental oxygen (O2)

Oxygen saturation during exertion is maintained at >= 88% on room air

Patients with history of lung disease currently requiring any supplemental oxygen treatment

Adequate pulmonary function as assessed by oxygen saturation >= 90% when ambulating and not requiring supplemental oxygen

Respiratory disease requiring continuous supplemental oxygen

Supplemental oxygen requirement > 6 L per minute

Supplemental oxygen requirement > 6 L per minute

Oxygen saturation < 90% despite supplemental oxygen > 6 L/min

Patients with RSV infection limited to the URT as documented by negative chest radiographic findings within the last 48 hours of enrollment and pulse oxygenation of more than 90 mm of Hg on room air

Patients with evidence of RSV LRI as documented by a positive rapid RSV antigen testing and/or culture on nasal washes AND new or progressive infiltrates on chest radiographic studies suggestive of viral etiology and/or pulse oxygen less than 90 mm of Hg on room air

Oxygen dependent

Oxygen saturation below 92% on room air

Adequate respiratory function with a room air oxygen saturation of at least 92%

Pulse oximetry of > 90% on room air

On chronic oxygen

Carbon monoxide diffusing capability test (DLCO) > 60% predicted and in children- room air oxygen saturation > 92%

Severe hypoxemia with room air partial pressure of oxygen (PaO2) < 70, supplemental oxygen dependence, or DLCO < 50% predicted

Required prior to infusion of ATLCAR.CD30 cells: Pulse oximetry of > 90% on room air

Room air desaturation at rest =< 85%

For children who are unable to perform pulmonary function testing, no evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry > 94% on room air

For children who are unable to perform pulmonary function testing, no evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry > 92% in room air

Pulse oximetry of hemoglobin saturation ?92% on room air

Oxygen saturation >= 90% on room air

Hypoxemia (less than 90% saturation with supplemental oxygen)

Current use of supplemental oxygen

Known severely impaired lung function (spirometry and DLCO 50% or less of normal and O2 saturation 88% or less at rest on room air)

Respiratory failure requiring greater than 6 Lpm supplemental oxygen (O2) by nasal cannula or mechanical ventilation within the past six weeks

Baseline oxygen saturation > 92% on room air

Patients must have documented pulse oximetry >= 92% on room air

Patients that require supplemental oxygen are excluded

Patients requiring continuous supplemental oxygen due to the requirement of spirometry during all imaging studies

Oxygen saturation < 90% on room air

Patients with history of lung disease currently requiring any pharmacologic or supplemental oxygen treatment

Requires daily supplemental oxygen.

Patients that require supplemental oxygen are excluded

Oxygen saturation >= 90% when ambulating and not requiring supplemental oxygen